Reactions Weekly

, Volume 1695, Issue 1, pp 57–57 | Cite as


Rash and major bleeding: 2 case report
Case report


  1. Storrar N, et al. Apixaban is safe and effective thromboprophylaxis in myeloma patients treated with immunomodulatory therapy. Blood 130 (Suppl. 1): 1872, 2017. Available from: URL: [abstract] - United KingdomGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations